» Articles » PMID: 29170852

T Cell Subsets: an Integral Component in Pathogenesis of Rheumatic Heart Disease

Overview
Journal Immunol Res
Date 2017 Nov 25
PMID 29170852
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Acute rheumatic fever (ARF) is a consequence of pharyngeal infection of group A streptococcal (GAS) infection. Carditis is the most common manifestation of ARF which occurs in 30-45% of the susceptible individuals. Overlooked ARF cases might further progress towards rheumatic heart disease (RHD) in susceptible individuals, which ultimately leads to permanent heart valve damage. Molecular mimicry between streptococcal antigens and human proteins is the most widely accepted theory to describe the pathogenesis of RHD. In the recent past, various subsets of T cells have been reported to play an imperative role in the pathogenesis of RHD. Alterations in various T cell subsets, viz. Th1, Th2, Th17, and Treg cells, and their signature cytokines influence the immune responses and are associated with pathogenesis of RHD. Association of other T cell subsets (Th3, Th9, Th22, and T) is not defined in context of RHD. Several investigations have confirmed the up-regulation of adhesion molecules and thus infiltration of T cells into the heart tissues. T cells secrete both Th type 1 and type 2 cytokines and these auto-reactive T cells play a key role in progression of heart valve damage. In this review, we are going to discuss about the role of T cell subsets and their corresponding cytokines in the pathogenesis of RHD.

Citing Articles

The impact of biologic agents on cardiovascular risk factors in patients with rheumatoid arthritis: A meta analysis.

Jia X, Yang Z, Li J, Mei Z, Jia L, Yan C PLoS One. 2024; 19(8):e0306513.

PMID: 39208032 PMC: 11361434. DOI: 10.1371/journal.pone.0306513.


Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association.

Small A, Yutzey K, Binstadt B, Key K, Bouatia-Naji N, Milan D Circulation. 2024; 150(6):e109-e128.

PMID: 38881493 PMC: 11542557. DOI: 10.1161/CIR.0000000000001254.


Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets.

Xia Y, Gao D, Wang X, Liu B, Shan X, Sun Y Front Immunol. 2024; 15:1331609.

PMID: 38558816 PMC: 10978666. DOI: 10.3389/fimmu.2024.1331609.


Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis.

Asrial A, Reviono R, Soetrisno S, Yuli Setianto B, Widyaningsih V, Nurwati I J Clin Med. 2023; 12(18).

PMID: 37762839 PMC: 10532082. DOI: 10.3390/jcm12185898.


The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer.

Gouttefangeas C, Klein R, Maia A Front Immunol. 2023; 14:1212546.

PMID: 37409132 PMC: 10319254. DOI: 10.3389/fimmu.2023.1212546.


References
1.
Rutz S, Eidenschenk C, Ouyang W . IL-22, not simply a Th17 cytokine. Immunol Rev. 2013; 252(1):116-32. DOI: 10.1111/imr.12027. View

2.
Krisher K, Cunningham M . Myosin: a link between streptococci and heart. Science. 1985; 227(4685):413-5. DOI: 10.1126/science.2578225. View

3.
Zenewicz L, Flavell R . Recent advances in IL-22 biology. Int Immunol. 2011; 23(3):159-63. DOI: 10.1093/intimm/dxr001. View

4.
Guilherme L, Dulphy N, Douay C, Coelho V, Cunha-Neto E, Oshiro S . Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol. 2000; 12(7):1063-74. DOI: 10.1093/intimm/12.7.1063. View

5.
Dinkla K, Talay S, Morgelin M, Graham R, Rohde M, Nitsche-Schmitz D . Crucial role of the CB3-region of collagen IV in PARF-induced acute rheumatic fever. PLoS One. 2009; 4(3):e4666. PMC: 2646144. DOI: 10.1371/journal.pone.0004666. View